VTN and lung cancer: Indeed, the beneficial effect of ApCAF in lung cancer is mediated partially through expression of complement proteins which rescue intratumoral T cells from exhaustion (Kerdidani et al., 2022) and this may provide a unifying explanation for the prognostic value of HLA class II and complement expression in this study.